Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
233 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (4)
  • (-) Currently Recruiting (2)
  • Closed (2)

Medical Condition

  • Show all (233)
  • Addiction (4)
  • Allergy, Asthma, & Immunology (1)
  • Autoimmune Disorders (3)
  • Bone & Muscle (2)
  • Cancer (10)
    • Breast Cancer (2)
    • Gynecologic Cancer (1)
    • Leukemia (3)
    • (-) Liver Cancer (1)
    • Lymphoma (1)
    • (-) Pancreatic Cancer (1)
  • COVID-19 (Coronavirus) (8)
  • Diabetes (7)
  • Ear, Nose and Throat (7)
  • Endocrine & Metabolic Disease (2)
  • Gastrointestinal and Digestive Diseases (3)
  • Healthy Volunteers (46)
  • Heart Disease (21)
  • Infectious Disease (11)
  • Insomnia (1)
  • Liver Disease (15)
  • Lung Disease (2)
  • Neurological Disorders (31)
  • Nutrition (2)
  • Obesity (8)
  • Obstetrics & Gynecology (10)
  • Pediatrics (14)
  • Psychiatric Disorders (7)
  • Rehabilitation (2)
  • Stroke (2)
  • Transplant (13)
  • Vascular Conditions (1)
Displaying 1 - 2 of 2

The Cancer of the Pancreas Screening-5 Study (CAPS5 Study)

Condition: Cancer / Pancreatic Cancer
Investigator: Fay Kastrinos, MD
Status: Currently Recruiting
Pancreatic cancer is a deadly disease and the best hope for improving the chances of survival is to find it early. Some patients, called "high risk", have an inherited predisposition to pancreatic cancer. Certain medical centers have started programs where "high risk patients" undergo testing, such as receiving imaging scans, to look for…
Read More

Liquid biopsy and radiomics for liver cancer surveillance

Condition: Cancer / Liver Cancer
Investigator: Elizabeth Verna, MD
Status: Currently Recruiting
This study aims to use new technology involving molecular and imaging tests to help detect liver cancer early in patients. Participants enrolled will participate in it for approximately 5 years. The purpose of this study is to determine if an experimental drug, INT-787, is safe and effective in patients who are hospitalized due to severe alcohol-associated…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science